Watchlist Price Alert

Cellectar Biosciences Inc... (CLRB)

NASDAQ: CLRB · Real-Time Price · USD

0.36

-0.00 (-0.22%)

At close: Jun 09, 2025, 3:59 PM

-0.22% (1D)

Bid	0.32
Market Cap	16.38M
Revenue (ttm)	n/a
Net Income (ttm)	-24.54M
EPS (ttm)	-0.63
PE Ratio (ttm)	-0.56
Forward PE	-0.64
Analyst	Buy

Ask	0.37
Volume	6,646,812
Avg. Volume (20D)	11,658,546
Open	0.35
Previous Close	0.36
Day's Range	0.33 - 0.38
52-Week Range	0.22 - 3.42
Beta	0.52

About CLRB

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CLRB

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CLRB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 week ago

-11.61%

Cellectar Biosciences shares are trading lower. Th... Unlock content with Pro Subscription

2 weeks ago

+66.32%

Cellectar Biosciences shares are trading higher after the company announced it was granted FDA Breakthrough Therapy Designation status for Iopofosine I-131.

News

3 weeks ago · zacks.com

4 Medical Product Stocks to Watch From a Challenging Industry

The U.S. government's tariff imposition, especially on China, is likely to keep supply chains under pressure for the Zacks Medical Products industry. PODD, MGNX, CLRB and ALUR reflect the favorable fu...

1 month ago · seekingalpha.com

Cellectar Biosciences Inc. (CLRB) Q1 2025 Earnings Call Transcript

Cellectar Biosciences Inc. (NASDAQ:CLRB ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Jim Caruso - President and CEO Chad Kolean - CFO Jarrod Longcor - COO Anne Marie...

2 months ago · zacks.com

4 Medical Product Stocks to Buy From a Challenging Industry

The U.S. government's tariff imposition, especially on China, is likely to keep supply chains under pressure for the Zacks Medical Products industry. PODD, MGNX, CLRB and ALUR are likely to gain from ...

3 months ago · zacks.com

Is Cellectar Biosciences (CLRB) Stock Outpacing Its Medical Peers This Year?

Here is how Cellectar Biosciences, Inc. (CLRB) and Cencora (COR) have performed compared to their sector so far this year.

3 months ago · seekingalpha.com

Cellectar Biosciences Inc. (CLRB) Q4 2024 Earnings Call Transcript

Cellectar Biosciences Inc. (NASDAQ:CLRB ) Q4 2024 Earnings Conference Call March 13, 2025 8:30 AM ET Company Participants Anne Marie Fields – Managing Director-Precision AQ Jim Caruso – President and ...